Early Phase 1 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are under 30 years of age
- People who have been diagnosed with Wilms tumor or clear cell sarcoma of the kidney (a type of kidney cancer) where radiation therapy is considered a standard part of treatment
- People whose Wilms tumor is classified as "favorable histology, stage III" (a specific cancer type and stage classification — confirm with trial site)
- People whose Wilms tumor involves a pattern called focal or diffuse anaplasia (an abnormal cell appearance — confirm with trial site)
- People diagnosed with clear cell sarcoma of the kidney (CCSK)
- People whose treating doctor has determined that external beam radiation therapy (a type of radiation treatment delivered from outside the body) is appropriate as standard care for their kidney cancer
Who may not be able to join:
- People who have previously received radiation therapy to the area of the body affected by the cancer being studied
- People who have already received chemotherapy for their Wilms tumor or clear cell sarcoma of the kidney diagnosis
- People who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christine Hill-Kayser, MD, Children's Hospital of Philadelphia
Phone: 215-590-2810
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurrence of any non-hematologic toxicity that occurs within 90 days following the start of proton therapy assessed with with NCI Common toxicity criteria (CTC Version 4.0) grades].
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.